24/02/2010 | The selective oestrogen receptor modulator raloxifene may have a role in treating postmenopausal women with schizophrenia, a small pooled analysis finds.
04/02/2010 | The Australian Drug Evaluation Committee has backed an application for an antipsychotic drug to be approved for use in children with schizophrenia.
04/02/2010 | Fish oil may protect young people at risk of schizophrenia from developing psychosis, Australian researchers have found.
03/02/2010 | Aerobic exercise increases hippocampal volume in patients with and without schizophrenia, but further studies are needed to determine its effectiveness as a long term treatment option in schizophrenic patients, a randomised study concludes.
03/02/2010 | The first atypical deltoid injection for schizophrenia and related psychoses has been added to the Pharmaceutical Benefits Scheme.
19/01/2010 | Sulpiride plus clozapine is likely to be more effective than clozapine alone to treat patients with treatment-resistant schizophrenia, but evidence is weak and more research is needed, a Cochrane review concludes.
03/12/2009 | Long-acting olanzapine pamoate was listed on the Pharmaceutical Benefits Scheme this week for the treatment of adult patients with schizophrenia who have been stabilised with oral olanzapine.
12/11/2009 | The number of community treatment orders doubled between 1998 and 2002, and most people subject to an order were prescribed antipsychotic long-acting injections, an Australian study finds.
04/11/2009 | Researchers from Melbourne have come up with a practical solution to address existing barriers in implementing cardiometabolic monitoring in patients prescribed antipsychotics.
04/11/2009 | The risk of suicide after first-episode psychosis remains high for at least seven years after starting treatment, and previous self-harm is the key predictor of a future suicide event, Australian research finds.